From: Endogenous assessment of chronic myocardial infarction with T1ρ-mapping in patients
Patients with MI (n = 21) | |
---|---|
Sex | 19 male, 2 female |
Age, years | 55.4 ± 8.7 |
BMI | 27.0 ± 3.2 |
Smoking | n = 6; 28.6% |
Hypertension | n = 10; 47.6% |
Diabetes | n = 3; 14.3% |
Hyperlipidemia | n = 13; 65% |
Family history of vascular disease | n = 5; 23.8% |
Antihypertensive drugs | n = 20; 95.2% (70% β-blockers, 25% Diuretics, 5% ACE-inhibitors) |
Statin use | n = 20; 95.2% |
Antithrombotic therapy | n = 21; 100% |
Age infarct, days | 263 ± 139 |
Lesion | n = 10; 47.6% LAD, n = 10; 47.6% RCA, n = 1; 4.8% LCX |
LV ejection fraction | 55.7 ± 7.4% |